China’s NMPA conditionally approves Boehringer’s tablets for NSCLC
The decision by the NMPA was informed by the outcomes of the Phase Ib Beamion-LUNG 1 study.
Clinical Trials
American Society of Clinical Oncology (ASCO) Annual Meeting 2025
China’s CDE grants breakthrough status approval to Abbisko’s HCC therapy
Seres’ SER-155 gains breakthrough status for BSIs reduction
CPI’s Medicines Manufacturing Innovation Centre takes delivery of PACE Just in Time (JIT) Clinical Trials Drug Dispensing System
Does Southeast Asia have a growing role in vaccine development?
AlloVir and Kalaris enter merger to advance retinal disease therapies
Invenra’s antibody gains US FDA designations for neuroblastoma treatment
